Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / ESCMID Global 2026 Faster Diagnostics at What Cost
Insights Point of care testing Screening and monitoring Infectious Disease Voices in the Community

ESCMID Global 2026: Faster Diagnostics at What Cost?

This year’s congress spotlights innovation and growing gaps in patient care

By Jessica Allerton 04/30/2026 Review 2 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Clinical Microbiology and Infectious Diseases Diagnostics

Institutions leading in this area are recognized for their pioneering research in rapid diagnostic technologies, antimicrobial stewardship programs, clinical microbiology innovation, and implementation of AI and advanced molecular techniques in infectious disease diagnostics.

  • #1

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins leads in translational research on rapid diagnostics for sepsis and antimicrobial resistance, with strong integration of AI and molecular diagnostics in clinical microbiology workflows.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Antimicrobial Stewardship
  • #2

    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    MGH and Harvard Medical School are at the forefront of developing and clinically validating novel rapid diagnostic technologies including nanoplasmonic and Raman spectroscopy methods, alongside AI-driven microbiology platforms.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Biomedical Engineering
  • #3

    University of Oxford

    Oxford, Oxfordshire

    Oxford excels in metagenomic diagnostics and antimicrobial resistance research, with significant contributions to rapid sequencing and AI-assisted diagnostic platforms in infectious diseases.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Genomics
  • #4

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF is recognized for its innovative work in rapid diagnostics for neonatal sepsis and bloodstream infections, combining advanced molecular diagnostics with AI and informatics to improve clinical outcomes.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Biomedical Informatics
  • #5

    Karolinska Institutet

    Stockholm, Stockholm County

    Karolinska Institutet is a leader in translational research on rapid infectious disease diagnostics and antimicrobial resistance, with strong emphasis on diagnostic stewardship and clinical implementation.

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Translational Medicine

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Insights
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Turning Tides
Insights
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Insights
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Navigating Digital Scholarship and Professional Growth
Insights
Navigating Digital Scholarship and Professional Growth

January 16, 2024

5 min read

How can new-in-practice pathologists leverage the power of social media to enhance traditional academic work?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.